Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?
Boudreaux's stake now totals ~172,000 directly held shares worth $63.51 million, as Elevance maintains an $80 billion market cap and $5.0 billion in trailing net income.
Overview
Gail Boudreaux, President and CEO of Elevance Health, Inc. (NYSE:ELV), purchased 2,725 shares of common stock on July 17, 2026, at $367.79 per share. SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($367.79); post-transaction value based on July 17, 2026 market close ($369.16).
Details
Elevance Health is one of the nation's largest health benefits organizations, commanding a significant market position with $201.1 billion in trailing twelve-month (TTM) revenue and serving over 118 million individuals. The company's integrated platform approach—combining medical plans, pharmacy management, behavioral health services, and digital health tools—provides a competitive advantage in delivering coordinated care and managing healthcare costs. Founded in 1944 and headquartered in Indianapolis, Elevance Health demonstrates substantial profitability with $5 billion in TTM net income, reflecting strong operational execution and market leadership in the managed care sector.
Source
Originally published at www.fool.com.